SPLICE: Surgical Planning and Informed Consent

Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (Other)
Overall Status
Completed
CT.gov ID
NCT03503487
Collaborator
(none)
40
1
3
20.4
2

Study Details

Study Description

Brief Summary

New devices for anatomic studies and 3-D visualization have proven to be useful for pre-operative surgical planning and intra-operative procedures; the hypothesis of our study is that, in this specific case scenario, Surgical Theater and Vesalius (two devices available at the Besta NeuroSim Center, Foundation I.R.C.C.S. Neurological Institute Carlo Besta) can improve doctor-patient communication during the process of obtaining informed consent: through tridimensional representation of anatomic structures of the brain, these devices are able to help patients understand better their own anatomy and the surgical approach to their disease.

The aim of our study is therefore to understand whether this high-technology 3D planning, used as a tool to optimize patient-doctor communication, can effectively improve patients' understanding of the disease and the surgical procedure they will be going through (for which they are supposed to sign the consent), as well as the benefits, the risks and all the possible complications that can derive form surgery.

Surgical Theater and Vesalius may be of great help: thanks to the case-specific 3D reconstruction of the patient's anatomy, the explanation of the surgical procedure could be customized for each different person, considering that anyone has certain unique individual features that a regular standardized system could not possibly take into account.

Detailed Description

Informed consent is the authorisation of an activity based on the understanding of what that activity entails in the absence of control by others. In surgery this process needs the comprehension of the benefits and the risks of the operation. Despite this, it has been argued that most surgeons do not devote adequate importance and time to this step in their daily practice; sometimes they are just afraid of scaring the patients with too many unnecessary details. Surgeons then might hide themselves behind legal booklets that should provide all information; too often though, patients do not fully realise their diseases and the possible outcomes.

New devices for anatomical studies and 3D visualization have proven to be useful for preoperative surgical planning and intra-operative procedures; the hypothesis of our study is that Surgical Theater and Vesalius (two new-generation, immersive, 3D imaging visualizers) can improve doctor-patient communication during the process of obtaining informed consent: through the tridimensional representation of anatomic structures of the brain, these devices are able to help patients better understand their anatomy, the surgical approach for their disease and possible complications.

In a prospective, randomized controlled pilot study, 40 patients undergoing neurosurgery for intracranial tumours were enrolled. Patients' cognitive function, verbal comprehension and memory were assessed before being enrolled. All groups initially underwent the standard informed consent process. Then the experimental groups received a second informed consent process with the aid of surgical planners, while the control group went through to a second round of standard informed consent. Questionnaires about appreciation, anxiety, and perceived and objective comprehension (on pathology, surgery, complications) were given.

Tridimensional surgical planners may be of great help in improving how technical information is conveyed to patients when consented for surgery. Considering that every individual has unique features, a standardised method cannot be taken into account, therefore, thanks to the case-specific 3D reconstruction of the patient's anatomy, the explanation of the surgical procedure can be customized for every patient. Using new 3D technologies is expected to reduce patients' anxiety and to improve the understanding of their conditions and the possible consequences related to any treatment options.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Surgical Planning and Informed Consent
Actual Study Start Date :
Jul 1, 2016
Actual Primary Completion Date :
Mar 15, 2018
Actual Study Completion Date :
Mar 15, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Patients receiving standard informed consent procedure before intervention

Experimental: Planner 1

Patients receiving 3D informed consent procedure before intervention with Surgical Theater

Other: 3D informed consent
Patients were given an informed consent with the aid of a 3D immersive surgical planner (either a Surgical Theater or Vesalius)

Experimental: Planner 2

Patients receiving 3D informed consent procedure before intervention with Vesalius

Other: 3D informed consent
Patients were given an informed consent with the aid of a 3D immersive surgical planner (either a Surgical Theater or Vesalius)

Outcome Measures

Primary Outcome Measures

  1. Evaluation of the comprehension of the benefits/risks of the intervention [1 year]

    Comprehension of the benefits/risks of the intervention evaluated through a ad hoc questionnaire

Secondary Outcome Measures

  1. Level of patient's anxiety [1 year]

    Anxiety score pre- and post- informed consent as assessed with the State-Trait Anxiety Inventory (STAI) Y-1 and Y-2

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • having a cerebral tumor

  • no visual/auditory deficit

  • no psychiatric illness

  • italian mother-tongue

Exclusion Criteria:
  • younger than 18 or older than 70

  • pre-existing perceptual deficit and/or psychiatric illness

  • not italian mother-tongue

Contacts and Locations

Locations

Site City State Country Postal Code
1 Foundation IRCCS Neurologic Institute Carlo Besta Milan Italy 20133

Sponsors and Collaborators

  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Investigators

  • Principal Investigator: Alessandro Perin, MD, PhD, Foundation IRCCS Neurologic Institute Carlo Besta

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eleonora Orena, Psychologist, Neuroscientist researcher, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
ClinicalTrials.gov Identifier:
NCT03503487
Other Study ID Numbers:
  • SPLICE
First Posted:
Apr 19, 2018
Last Update Posted:
Apr 19, 2018
Last Verified:
Apr 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 19, 2018